Recently the Netherlands decided to cancel the more than 40,000 appointments of AstraZeneca vaccine. Moreover, this vaccine from Oxford University will not be available there for at least two weeks. On the other hand, medical reports from Norwegian Medical agencies shows blood clotting events due to this vaccine.
After the Norwegian report, Ireland also decided to stop the vaccine’s rollout temporarily. However, the World Health Organisation has urged countries to keep using the vaccine.
Now, AstraZeneca has released a new statement defending the usage of the vaccine. They’ve added there’s no possible evidence of an increased risk of blood clotting in any gender or age group due to their vaccine. Moreover, the experts reviewed the data carefully and it includes more than 17 million vaccinated people.
Republic of Ireland’s Deputy Chief Medical Officer, Dr Ronan Glynn, suggested the stop on AstraZeneca vaccine. He further added that there’s no conclusion on links between the vaccine and blood clotting. But they need to act on prudent principals.
Other countries, along with Ireland and the Netherlands
Many other countries like Denmark, Iceland and Norway have already halted the AstraZeneca vaccine’s rollout. However, Ireland’s neighbour, Northern Ireland, will keep using the vaccine and seek advice from the UK’s medicines regulator.
The Health Service of Northern Ireland stated that their country would continue the vaccine rollout programme. Moreover, a further expansion of this programme will be announced soon.